Page 8 - Seption Group News Today

01.21.21 -- Using Production And Postmarket Data To Validate FMEA Assumptions   Acepodias Dr. Sony Hsiao, CEO, and Dr. Mark Gilbert, SVP of R&D, join Business of Biotech for a discussion on the companys approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates. Listen now and subscribe so you never miss an episode. Featured Editorial By Mark Durivage, Quality Systems Complian...